3 news items
Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
GOSS
6 May 24
of life and act responsibly towards both the community and the environment.
By changing its legal status
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
GOSS
12 Mar 24
Faheem Hasnain, Co-Founder, Chairman and CEO of Gossamer Bio. "It not only demonstrates our dedication to the PH community, but it also solidifies our
Goldman Sachs Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
GOSS
6 Mar 24
. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst
- Prev
- 1
- Next